Drug Type Bispecific antibody |
Synonyms- |
Target |
Mechanism CD3 inhibitors(T cell surface glycoprotein CD3 inhibitors), Trop-2 inhibitors(Tumor-associated calcium signal transducer 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Triple Negative Breast Cancer | Preclinical | CN | 09 Oct 2021 | |
Triple Negative Breast Cancer | Preclinical | CN | 09 Oct 2021 |